MindBio Therapeutics (MBIO) | WebDisclosure

Basculer en Français

8228	Companies
111072	Keywords
52793	Articles
60962	Press releases

Home
Companies
MindBio Therapeutics

BRIEF

published on 05/02/2024 at 10:05, 6 months 6 days ago

MindBio Therapeutics Advances Women’s Health and Depression Treatment Trials

Clinical Trials Microdosing LSD MindBio Therapeutics Women's Health Depression Treatment
BRIEF

published on 05/02/2024 at 10:05, 6 months 6 days ago

MindBio Therapeutics fait progresser les essais sur la santé des femmes et le traitement de la dépression

Essais Cliniques MindBio Thérapeutique Microdosage Du LSD Santé Des Femmes Traitement De La Dépression
PRESS RELEASE

published on 05/02/2024 at 10:00, 6 months 6 days ago

MindBio Therapeutics Scientists Present Landmark Women’s Health Trials. Company To Release Phase 2A Depression Trial Secondary Data This Month
MindBio Therapeutics Corp. presents groundbreaking women's health trials for microdosing treatments, showcasing Dr. Rachael Sumner and upcoming data release on Phase 2A trial results. Chief Executive Justin Hanka discusses future growth plans

Clinical Trials Mental Health MindBio Therapeutics Corp. Women's Health Trials Microdosing Treatments
PRESS RELEASE

published on 05/02/2024 at 10:00, 6 months 6 days ago

MindBio Therapeutics Scientists Present Landmark Women’s Health Trials. Company To Release Phase 2A Depression Trial Secondary Data This Month
MindBio Therapeutics Corp. showcases women's health trials and upcoming data presentation on Phase 2A trial of MB22001 for Major Depressive Disorder. Company pioneering microdosing LSD for mental health conditions

MindBio Therapeutics Corp. MB22001 Microdosing LSD Women's Health Trials Phase 2A Trial
BRIEF

published on 05/01/2024 at 11:25, 6 months 7 days ago

MindBio Therapeutics explore la double inscription au milieu d'essais cliniques réussis

Depression Phase 2b Essais Cliniques MindBio Thérapeutique Microdosage Du LSD
BRIEF

published on 05/01/2024 at 11:25, 6 months 7 days ago

MindBio Therapeutics Explores Dual Listing Amid Successful Clinical Trials

Clinical Trials Microdosing LSD Phase 2b MindBio Therapeutics Depressive Disorder
PRESS RELEASE

published on 05/01/2024 at 11:20, 6 months 7 days ago

MindBio Is Exploring Dual Listing on A Senior Exchange with Multiple Phase 2B Clinical Trials Underway Supported by Positive Trial Data and Planning for Phase 3
MindBio announces successful completion of Phase 1 and Phase 2a Clinical Trials for MB22001 in treating Major Depressive Disorder. Company plans dual listing on senior exchange

Dual Listing Clinical Trials MB22001 MindBio Therapeutics Depressive Disorder
BRIEF

published on 04/30/2024 at 12:10, 6 months 8 days ago

MindBio Therapeutics lance des essais cliniques révolutionnaires pour la santé des femmes

MB22001 Essais Cliniques Microdosage Du LSD Santé Des Femmes PMS Et PMDD
BRIEF

published on 04/30/2024 at 12:10, 6 months 8 days ago

MindBio Therapeutics Launches Groundbreaking Clinical Trials for Women's Health

Clinical Trials MB22001 Microdosing LSD Women's Health PMS And PMDD
PRESS RELEASE

published on 04/30/2024 at 12:05, 6 months 8 days ago

MindBio Therapeutics Announces Landmark Women’s Health CNS Drug Trials
MindBio Therapeutics Corp. has received regulatory approval for clinical trials using MB22001 to address PMS and PMDD in menstruating individuals. The trials aim to assess the drug's mood-related effects during different menstrual phases

Clinical Trials MindBio Therapeutics Corp. MB22001 PMS PMDD

Accesswire

Published on 11/08/2024 at 14:00, 27 minutes ago

NOA Lithium Closes $912,596 1st Tranche of the $2.7 Million Non-Brokered Private Placement
Published on 11/08/2024 at 14:00, 27 minutes ago

Ballpoint Marketing - Leader in Handwritten Mail - Acquires a Friendly Competitor: Robot Ink Marketing
Published on 11/08/2024 at 13:30, 57 minutes ago

Moderna Receives Health Canada Approval for RSV Vaccine for Adults Aged 60 Years and Older
Published on 11/08/2024 at 13:05, 1 hour 22 minutes ago

Aton Announces Corporate and Operations Update
Published on 11/08/2024 at 13:00, 1 hour 27 minutes ago

Honey Badger Announces Change of Transfer Agent

View all ACCESSWIRE

EQS Group

Published on 11/08/2024 at 14:00, 27 minutes ago

Form 8.3 - Zürcher Kantonalbank: Tritax EuroBox PLC
Published on 11/08/2024 at 12:31, 1 hour 56 minutes ago

Original-Research: ORBIS SE (von GSC Research GmbH): Kaufen
Published on 11/08/2024 at 12:30, 1 hour 57 minutes ago

Holding(s) in Company
Published on 11/08/2024 at 12:25, 2 hours 2 minutes ago

freenet Executive Board formulates financial ambition until 2028 - EBITDA and free cash flow to grow significantly
Published on 11/08/2024 at 12:11, 2 hours 16 minutes ago

PNE AG selected by the European Commission for funding a project to produce hydrogen

Les Echos

Published on 11/08/2024 at 12:32, 1 hour 55 minutes ago

Louis Hachette Group announces the publication of its Information Document for listing on Euronext Growth (Paris)
Published on 11/08/2024 at 12:32, 1 hour 55 minutes ago

Louis Hachette Group annonce la publication de son Document d’Information en vue de sa cotation sur Euronext Growth (Paris)
Published on 11/08/2024 at 12:15, 2 hours 12 minutes ago

Louis Hachette Group announces the publication of its Information Document for listing on Euronext Growth (Paris)
Published on 11/08/2024 at 12:15, 2 hours 12 minutes ago

Louis Hachette Group annonce la publication de son Document d’Information en vue de sa cotation sur Euronext Growth (Paris)
Published on 11/08/2024 at 08:00, 6 hours 27 minutes ago

DAMARTEX / Droits de vote bruts et réels 31 octobre 2024

View all LES ECHOS COMFI WIRE